1-Bromo-4-methoxy-2-methyl-3-nitrobenzene, 95+%, 5g

N,N-Dimethyl-N'-(3-thioxo-3H-1,2,4-dithiazol-5-yl)formimidamide, 95.0%, 100g

2-(2,4-Dihydroxyphenyl)-4,6-diphenyl-1,3,5-triazine>98.0%(HPLC)(N)5g

2-Phenyl-4,5-dihydrooxazole, 95.0%, 1g

Kojic acid, 99.0%, 100g

ethyl 4-(5-fluoro-2-methoxyphenyl)-2,4-dioxobutanoate, 1g

(R)-2,6-Dichloro-3-fluoro-alpha-methylbenzyl Alcohol>98.0%(GC)5g

2-(3-ethyl-1,2,4-oxadiazol-5-yl)aniline, 95.0%, 5g

4-Bromo-8-methoxy-2-methylquinoline, 97%, 10g

1-Hydroxy-2,2,6,6-tetramethylpiperidin-4-yl 3,3-bis((3aS,8aR)-3a,8a-dihydro-8H-indeno[1,2-d]oxazol-2-yl)butanoate (free radical), 97%, 100mg

Methyl 4-Chlorobutanimidoate hydrochloride, 97.0%, 5g

3-(Piperidin-4-ylmethyl)-1H-indole, 95.0%, 250mg

3-Bromo-2-(difluoromethyl)-6-methoxypyridine, 1g